PortfoliosLab logoPortfoliosLab logo
NKTR vs. APLD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NKTR vs. APLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nektar Therapeutics (NKTR) and Applied Digital Corporation (APLD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NKTR achieves a 67.15% return, which is significantly higher than APLD's 11.70% return. Over the past 10 years, NKTR has underperformed APLD with an annualized return of -12.14%, while APLD has yielded a comparatively higher 111.35% annualized return.


NKTR

1D
-1.09%
1M
-0.52%
6M
89.31%
YTD
67.15%
1Y
207.80%
3Y*
108.39%
5Y*
-21.49%
10Y*
-12.14%
ALL TIME*
0.66%

APLD

1D
-2.07%
1M
-17.15%
6M
-19.16%
YTD
11.70%
1Y
118.77%
3Y*
43.55%
5Y*
84.53%
10Y*
111.35%
ALL TIME*
26.17%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$653.03M$590.08M$826.73M
$53.73M$57.41M$67.60M

NKTR vs. APLD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NKTR
Nektar Therapeutics
67.15%203.08%64.60%-75.00%-83.27%-20.53%-21.26%-34.32%-44.96%386.72%
APLD
Applied Digital Corporation
11.70%220.94%13.35%266.30%-56.09%11,789.90%389.44%-34.55%64.99%-33.33%

Correlation

The correlation between NKTR and APLD is 0.19, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.19

Correlation (3Y)
Balances recent behavior with more history.

0.22

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.21

Correlation (10Y)
Provides a long-term view across more market conditions.

0.13

Correlation (All Time)
Calculated using the full available price history since Oct 22, 2008

0.08

The correlation between NKTR and APLD shifts across timeframes, from 0.08 (all time) to 0.22 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NKTR:

$1.38B

APLD:

$7.83B

EPS

NKTR:

-$8.02

APLD:

-$0.91

PS Ratio

NKTR:

25.03

APLD:

12.10

PB Ratio

NKTR:

3.03

APLD:

4.57

Total Revenue (TTM)

NKTR:

$55.63M

APLD:

$611.31M

Gross Profit (TTM)

NKTR:

$44.58M

APLD:

$214.45M

EBITDA (TTM)

NKTR:

-$121.05M

APLD:

-$158.14M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NKTR vs. APLD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NKTR
NKTR Risk / Return Rank: 9494
Overall Rank
NKTR Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
NKTR Sortino Ratio Rank: 9696
Sortino Ratio Rank
NKTR Omega Ratio Rank: 9393
Omega Ratio Rank
NKTR Calmar Ratio Rank: 9595
Calmar Ratio Rank
NKTR Martin Ratio Rank: 9191
Martin Ratio Rank

APLD
APLD Risk / Return Rank: 7878
Overall Rank
APLD Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
APLD Sortino Ratio Rank: 8080
Sortino Ratio Rank
APLD Omega Ratio Rank: 7575
Omega Ratio Rank
APLD Calmar Ratio Rank: 7979
Calmar Ratio Rank
APLD Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NKTR vs. APLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nektar Therapeutics (NKTR) and Applied Digital Corporation (APLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NKTRAPLDDifference
Sharpe ratioReturn per unit of total volatility

+1.50

Sortino ratioReturn per unit of downside risk

+1.61

Omega ratioGain probability vs. loss probability

1.41

1.23

+0.18

Calmar ratioReturn relative to maximum drawdown

4.89

2.05

+2.84

Martin ratioReturn relative to average drawdown

9.90

4.56

+5.34

NKTR vs. APLD - Sharpe Ratio Comparison

The current NKTR Sharpe Ratio is 2.53, which is higher than the APLD Sharpe Ratio of 1.03. The chart below compares the historical Sharpe Ratios of NKTR and APLD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NKTR vs. APLD - Drawdown Comparison

The maximum NKTR drawdown since its inception was -99.61%, roughly equal to the maximum APLD drawdown of -99.73%. Use the drawdown chart below to compare losses from any high point for NKTR and APLD.


Loading charts...

Drawdown Indicators


NKTRAPLDDifference

Max Drawdown

Largest peak-to-trough decline

-99.61%

-99.73%

+0.12%

Max Drawdown (1Y)

Largest decline over 1 year

-46.54%

-53.23%

+6.69%

Max Drawdown (3Y)

Largest decline over 3 years

-73.20%

-71.95%

-1.25%

Max Drawdown (5Y)

Largest decline over 5 years

-97.76%

-82.61%

-15.15%

Max Drawdown (10Y)

Largest decline over 10 years

-99.61%

-89.80%

-9.81%

Current Drawdown

Current decline from peak

-95.66%

-44.83%

-50.83%

Average Drawdown

Average peak-to-trough decline

-68.44%

-74.51%

+6.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.94%

23.87%

-0.93%

Volatility

NKTR vs. APLD - Volatility Comparison

The current volatility for Nektar Therapeutics (NKTR) is 15.44%, while Applied Digital Corporation (APLD) has a volatility of 32.97%. This indicates that NKTR experiences smaller price fluctuations and is considered to be less risky than APLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NKTRAPLDDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.44%

32.97%

-17.53%

Volatility (6M)

Calculated over the trailing 6-month period

60.68%

76.00%

-15.32%

Volatility (1Y)

Calculated over the trailing 1-year period

89.80%

109.72%

-19.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

122.06%

164.94%

-42.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

97.22%

301.14%

-203.92%

Dividends

NKTR vs. APLD - Dividend Comparison

Neither NKTR nor APLD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NKTR vs. APLD - Financials Comparison

This section allows you to compare key financial metrics between Nektar Therapeutics and Applied Digital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


NKTR and APLD have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

APLD has higher volatility (32.97%) compared to NKTR (15.44%). In terms of maximum drawdown, NKTR dropped -99.61% vs APLD's -99.73%.

NKTR currently has the higher Sharpe Ratio (2.53 vs 1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NKTR and APLD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer